Mar 07, 2022 / 06:05PM GMT
Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division - Senior Medical Supplies and Devices Analyst
All right. Good afternoon. I think we're going to get started here. Thanks for joining us, and congrats on passing the COVID protocols. My name is Jayson Bedford. I cover medical devices here at Raymond James, and it's really our privilege to have with us the senior management team from Insulet. With us, we have the company's CEO, Shacey Petrovic. We have the company's CFO, Wayde McMillan. And Deb Gordon, VP of Investor Relations, is down in front here.
So with that, I'm going to hand it off to Shacey, and then we'll jump into some more interactive Q&A.
Shacey Petrovic - Insulet Corporation - President, CEO & Director
Great. Thanks, Jayson. And we appreciate being here, you hosting us and for the opportunity to share some opening remarks. What I thought I would just share is, it is an incredibly exciting time today at Insulet. And for our company and for our customers, which you'll see on the screen behind me, these are
Insulet Corp at Raymond James Institutional Investors Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot